Spero Therapeutics, Inc. SPRO Q2 2025 earnings
Reported August 12, 2025 · After market close
Revenue$11.8MBeat by $802.0K
EPS-$0.03Beat by $0.35
Revenue estimate$11.0M
EPS estimate-$0.38
Next report
Aug 11, 2026 (In 1 week)Revenue estimate$281.9K
EPS estimate-$0.17
Versus estimates
Revenue
Diluted EPS
Ask the moment Spero Therapeutics, Inc. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Spero Therapeutics, Inc. report Q2 2025 earnings?
- Spero Therapeutics, Inc. (SPRO) reported Q2 2025 earnings on August 12, 2025 after market close.
- What were Spero Therapeutics, Inc.'s Q2 2025 revenue and EPS?
- Spero Therapeutics, Inc. reported revenue of $11.8M and eps of $-0.03 for Q2 2025.
- Did Spero Therapeutics, Inc. beat estimates in Q2 2025?
- Revenue beat the consensus estimate of $11.0M by $802.0K. EPS beat the consensus estimate of $-0.38 by $0.35.
- How did Spero Therapeutics, Inc.'s Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 96.1% from $6.0M a year earlier and eps grew 90.9% from $-0.33.
- Where can I find Spero Therapeutics, Inc.'s Q2 2025 SEC filings?
- You can read the 10-Q periodic report (0000950170-25-107388) directly on SEC EDGAR. The filing index links above go to sec.gov.